What is the ticker symbol for AzurRx BioPharma?

AzurRx BioPharma trades under the ticker AZRX on NASDAQ.

What sector does AzurRx BioPharma operate in?

AzurRx BioPharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AZRX in a portfolio?

PortView shows AZRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

AzurRx BioPharma (AZRX) Stock Analysis

NASDAQHealthcareBiotechnology

$3.45+2.07%

52-week range$3.45

$2.68$26.30

Track AZRX in your portfolio for free · Portfolio tracker

What AzurRx BioPharma does

AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).

Key metrics

Market cap

$3.43M

P/E (TTM)

-1.84

EPS (TTM)

$-1.87

Beta

1.51

Dividend yield

0.00%

Revenue / share

$0.02

50-day avg

$4.94

200-day avg

$7.50

52-week high

$26.30

52-week low

$2.68

CEO

James Sapirstein

ETFs linked to AZRX

Broad-market and Healthcare sector ETFs an investor holding AzurRx BioPharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AZRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AZRX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for AzurRx BioPharma?: AzurRx BioPharma trades under the ticker AZRX on NASDAQ.
Which exchange is AZRX listed on?: AZRX is listed on NASDAQ.
What sector does AzurRx BioPharma operate in?: AzurRx BioPharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AZRX in a portfolio?: PortView shows AZRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.